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Abstract
Virus infection triggers a CD8+ T cell response that aids in virus clearance, but also expresses effector functions that may
result in tissue injury. CD8+ T cells express a variety of activating and inhibiting ligands, though regulation of the expression
of inhibitory receptors is not well understood. The ligand for the inhibitory receptor, NKG2A, is the non-classical MHC-I
molecule Qa1b, which may also serve as a putative restricting element for the T cell receptors of purported regulatory CD8+
T cells. We have previously shown that Qa1b-null mice suffer considerably enhanced immunopathologic lung injury in the
context of CD8+ T cell-mediated clearance of influenza infection, as well as evidence in a non-viral system that failure to
ligate NKG2A on CD8+ effector T cells may represent an important component of this process. In this report, we examine the
requirements for induction of NKG2A expression, and show that NKG2A expression by CD8+ T cells occurs as a result of
migration from the MLN to the inflammatory lung environment, irrespective of peripheral antigen recognition. Further, we
confirmed that NKG2A is a mediator in limiting immunopathology in virus infection using mice with a targeted deletion of
NKG2A, and infecting the mutants with two different viruses, influenza and adenovirus. In neither infection is virus clearance
altered. In influenza infection, the enhanced lung injury was associated with increased chemoattractant production,
increased infiltration of inflammatory cells, and significantly enhanced alveolar hemorrhage. The primary mechanism of
enhanced injury was the loss of negative regulation of CD8+ T cell effector function. A similar effect was observed in the
livers of mutant mice infected intravenously with adenovirus. These results demonstrate the immunoregulatory role of CD8+
NKG2A expression in virus infection, which negatively regulates T cell effector functions and contributes to protection of
tissue integrity during virus clearance.
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Introduction
Acute virus infection results in induction of innate immune
responses, which serve to contain replication as well as enhance
activation of adaptive responses. The adaptive responses are
critical to clearance of the virus, though at potentially significant
cost to the host. The cost to the host depends upon multiple
factors, in particular the kinetics of virus replication (and hence
antigen load) relative to the kinetics of T cell activation, acquisition
of effector activity, and magnitude of the response. Dispropor-
tionate kinetics may lead to a potent T cell response encountering
a large antigen load resulting in significant tissue destruction [1,2].
The consequences to the host also depend to a tremendous extent
on the particular tissue involved in the infection and clearance.
The lung is an example of an organ to which considerable injury is
unlikely to be compatible with host survival, depending upon the
specific components of the respiratory system involved. An
overwhelming infection of large airways, coupled with a robust
T cell response, would likely result in considerable morbidity (as in
the 1957 influenza pandemic), and significant susceptibility to
secondary bacterial pneumonia (resulting from multiple potential
mechanisms currently under investigation [3–7]). In contrast, the
significant mortality attributed to infection with avian strains (such
as H5N1 [8]) and likely to extraordinary mortality observed in the
1918 pandemic (characterized by an unusual mortality distribu-
tion, and descriptions from the period, which include instances of
very short intervals between first symptoms and death [9]) are
likely attributable to multiple factors, including highly efficient
replication [10], as well as viral tropism for the distal airways, i.e.
the alveolar epithelium [10,11]. Significant injury to alveolar
epithelial cells may have an enormous impact on respiratory gas
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exchange, which is often incompatible with host survival [12].
CD8+ T cell effector mechanisms are particularly important
contributors to the immunopathology observed in response to
virus infection [13–15].
The initial activation of T cell responses is thought to involve
multiple early events which are ‘‘programmed’’, and though there
are a number of early modifiers of the magnitude of the T cells
[16–18], there are parallel mechanisms which are induced to
counteract potentially deleterious effector functions, some of which
are extrinsic to the effector CD8+ T cells, such as Tregs [19,20],
and some of which are intrinsic to the effector cells. Some intrinsic
mechanisms include effector cell IL-10 production [21], as well as
induced expression of surface molecules that deliver inhibitory
signals upon ligation, such as CTLA-4, PD-1, Lag-3, CD160, and
others [22]. One such inhibitory molecule whose expression is
induced upon effector CD8+ T cells is NKG2A, which is expressed
as a heterodimer with CD94 [23–25]. Though expressed
constitutively on most NK cells, NKG2A is a product of the
KLRC1 gene and is a member of a family of inhibitory NK
receptors (iNKR), all originally described on NK cells but more
recently found on other cell types, though primarily CD8+ T cells
[24–29]. The interaction of iNKRs on CD8+ T cells with MHC
class I ligands on APCs has been proposed to allow for fine-tuning
TCR-mediated activation of CD8+ T cells [30,31]. Among NKRs,
the CD94/NKG2A heterodimer which recognizes the non-classic
MHC class I molecules HLA-E in human and Qa-1b in mouse, is
conserved between human and mouse. Because of the short
cytoplasmic tail on CD94, engagement of CD94/NKG2A
heterodimer with its receptor transduces a negative signal through
the two intracytoplasmic immunoreceptor tyrosine-based inhibi-
tory motifs (ITIM) of NKG2A molecule [31]. We [28] and others
[25,32] have shown that CD94/NKG2A engagement on antiviral
CD8+ T cells may be associated with dampened effector activity
(e.g., cytotoxicity, cytokine production), and we have also shown
induction of NKG2A expression on antigen specific CD8+ T cell
following influenza infection in mice [28]. We further demon-
strated that mice deficient in Qa1b exhibit enhanced immunopa-
thology upon CD8+ T cell-mediated clearance of influenza
infection [28]. Additionally, studies in a non-infectious model of
CD8+ T cell-mediated lung injury, antibody blockade of NKG2A
enhanced lung pathology, in large part by augmenting the release
of inflammatory cytokine TNF-a upon TCR engagement, which
we have previously shown to be a critical mediator of pulmonary
immunopathology [13,14,33–35].
An alternative role for the Qa1b has been proposed as the
restricting element for a novel CD8+ regulatory T cell [36],
offering an alternative interpretation of the enhanced immunopa-
thology we observed in influenza-infected Qa1b2/2 mice. In order
to formally confirm that this phenotype was due, at least to a
significant extent, to the absent engagement of NKG2A on
effector CD8+ T cells, we generated mice with a targeted deletion
of the NKG2A and observed their responses to virus infection.
Upon infection of these mutants we observed enhanced tissue
injury in immune-mediated clearance of two model virus
infections, influenza and adenovirus, in the lung and the liver,
respectively, supporting an important role for NKG2A in limiting
effector CD8+ T cell function.
Materials and Methods
Ethics statement
All mice were treated humanely and all studies were conducted
in accordance with guidelines approved by the Association for
Assessment and Accreditation of Laboratory Animal Care
Figure 1. NKG2A2/2 expression inversely correlates to influ-
enza viral load with peak expression at 12 days p.i. Mice were
intranasally infected with a 0.5LD50 Influenza A/PR8/34 virus and
sacrificed on the indicated days post infection. Whole lung viral titers
were determined by the TCID50 assay, solid black squares. In parallel,
lungs were harvested and NKG2A expression on NP366-specific CD8
+ T
cells was determined by FACS on the indicated days post- infection,
open squares. Data are representative of at least 3 independent
experiments.
doi:10.1371/journal.pone.0108385.g001
Figure 2. Expression of NKG2A does not require peripheral
cognate antigen recognition. A. Donor Influenza A/PR8/34-specific
CD8+ T cells isolated from Day 4 p.i. mediastinal lymph nodes were
transferred into recipient mice undergoing an irrelevant Influenza B/Lee
virus infection on day 4p.i. Cells were isolated from recipient mice at 8
days post influenza B/Lee infection and stained with antibodies for
CD90.1 (Thy1.1), CD90.2 (Thy1.2), CD8 and NKG2A. Red area denotes
NKG2A expression on recipient CD8+ T cells in the MLN. Blue line
denotes NKG2A expression on transferred CD8+ T cells in the MLN.
Green line denotes NKG2A expression on transferred CD8+ T cells in the
lung. Data represents 3 mice per group pooled. Shown is a
representative experiment of at least two independent experiments.
doi:10.1371/journal.pone.0108385.g002
NKG2A Abrogates Immune-Mediated Tissue Injury
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(AALAC) using a protocol (enel.ri.1) approved by the Institutional
Animal Care and Use Committee (IACUC) at the Geisel School of
Medicine at Dartmouth. In accordance with our IACUC
approved protocol, mice were euthanized via CO2 inhalation
under anesthesia or anesthesia overdose and exsanguination. A
composite endpoint was used as a surrogate for survival and mice
were sacrificed, as above, either after losing $20% of the initial
body weight, or other signs of severe illness, such as huddling and
piloerection.
Mice, viruses and infections
BALB/c mice 6–10 weeks old were purchase from Taconic
(Germantown, NY), C57BL/6 mice 6–10 weeks old were
purchased from the Jackson Laboratories (Bar Harbor, ME) and
NKG2A2/2 mice were generated as described below. Mice were
intranasally infected with 0.5LD50 influenza A/PR8/34 (H1N1)
virus, a mouse adapted laboratory strain. Recombinant adenovirus
expressing ovalbumin (Ad-OVA) was generously provided by Dr.
Timothy L. Ratliff (University of Iowa) and the Iowa Gene
Transfer Vector Core (Iowa City, IA). Mice were infected with
56108 PFU of rAd per mouse by IV immunization.
Generation of NKG2A-deficient mice
129v/Sj ES cells (ATCC) were maintained on a layer of
mitomycin C-treated MEFs, supplemented with LIF and 15%
FBS. Briefly a clone containing the mouse NKG2A/KLRC1 gene
(NCBI gene ID:16641) was isolated from a 129/J mouse genomic
library. A targeting vector was designed to replace exons 1 and 2
(as well as part of exon 3) and was generated with a 1.63 kb short
arm, and 4.68 kb long arm with a neo insert in between. The
insert was flanked on the 59 end with CMV promoter-driven
thymidine kinase gene. The vector was linearized with cla1 and
electroporated into cultured ES cells, and cultured for 10 days in
G418 and gancyclovir. The surviving clones were screened with
PCR, and confirmed by Southern blot after Nco1 digestion.
Several clones were chosen and microinjected into 129Sj
blastocysts prior to implantation in pseudo pregnant females.
Speed congenic backcrossing into the B6 background was
performed in conjunction with Dartmouse (Lebanon, NH) using
high-density SNP chips, as described [37].
Antibodies and flow cytometry
All antibodies for flow cytometry were purchased from
Biolegend, eBioscience, or BD biosciences. MHC-I/peptide
tetramers were synthesized and provided by the NIH tetramer
core facility (Atlanta, GA). Anti-mouse CD16/32 was purchased
from DartLab (Lebanon, NH). Data was acquired on a BD
FACScalibur and analyzed with FlowJo software (Tree Star,
Ashland, OR).
Histopathologic evaluation of lung injury
Mice were sacrificed at the indicated time points by ketamine/
xylazine anesthesia overdose followed by exsanguination accord-
ing to IACUC approved protocol. Lungs were then perfused with
Figure 3. NKG2A gene knockout schema and Southern Blot. A. Schematic of the KLRC1 (NKG2A) gene showing the region of substitution of
Neo cassette and the location of NcoI digestion sites used in generating gene fragments for southern blot for confirmation of the knockout genotype.
B. Genotyping of NKG2A2/2 by southern blot. Lane 1 shows both WT (12 kb) and NKG2A2/2 (8 kb) NcoI digest fragments in heterogeneous mice,
lane 2 homozygous WT (12 kb) band and lane 3 homozygous NKG2A2/2 (8 kb). The probe sequence is provided as Figure S1.
doi:10.1371/journal.pone.0108385.g003
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20 cc PBS at 25 cm H2O pressure. The tracheae were cannulated
and lungs inflated with 0.5% LMP agarose. FFPE lung tissue
sections were stained with hematoxylin and eosin, and the extent
of lung injury was evaluated. Evaluation of pathological severity
was performed in a blinded manner adapted from the methods
described previously [38,39],[40] by independently scoring of four
parameters: alveolar congestion, hemorrhage, aggregation of
neutrophil or leukocyte infiltration, and thickness of the alveolar
wall. The area of lung sections with evidence of any of these
abnormalities were measured, summed, and expressed as an
percentage of the total area of the field, and a minimum of 12
fields per slide were evaluated (slides represented serial sampling of
whole lung mounts separated by 10 mm levels.)
Luminex assay and BALF albumin quantitation
Mice were sacrificed at the indicated time point and the trachea
was exposed and cannulated. Bronchoalveolar lavage (BAL) was
performed by flushing 1 ml of sterile PBS/HALT protease
inhibitor cocktail (Thermo Pearce) back and forth 4 times.
Cytospin preparations were performed on freshly diluted BAL
fluid, and 30 randomly chosen high-power fields were photo-
graphed in a blinded fashion from each experimental group, and
RBC were counted in each field. Remainder of collected BALF
was centrifuged for 5 min. 6400 g to generate a cell free
supernatant and subsequently frozen until analysis. Frozen BALF
was thawed and assayed using Millipore Mouse 32-plex Luminex
assay to determine the expression of cytokines and chemokines.
BAL fluid albumin was analyzed by ELISA (Bethyl Laboratories,
Montgomery, TX).
Adoptive transfer
NP366-specific CD8
+ T cells from WT and NKG2A2/2 were
removed from culture 5 days after in vitro re-stimulation and
expansion, and subjected to histopaque density centrifugation to
remove irradiated stimulator cells. 16106 WT or NKG2A2/2
NP-specific cells were adoptively transferred by tail vein injection
into WT mice that were intranasally infected 1 day prior with a
lethal dose of Influenza PR8. Mice were monitored daily for
weight change, sacrificed 5 days post infection and lungs were
removed and processed for histological examination.
Statistical analyses
Statistical analysis was performed with GraphPad Prism
(GraphPad Software Inc., La Jolla, CA) using a two-tailed
unpaired t-test with 95% confidence interval. Data are presented
as mean 6 standard deviation.
Figure 4. Expression of NKG2A on antigen specific CD8+ T cells fromWT and NKG2A2/2 influenza infected mice.Mice were intranasally
infected with a sub-lethal dose of influenza A/PR8/34 and bronchoalveolar lavage was performed on day 10 post-infection. Isolated cells were stained
with NP366 tetramers and antibodies specific for CD44, CD8 and NKG2A,C,E or NKG2A
b6. Surface expression was determined by FACS. Average values
for CD4+, CD8+ and NP366 specific -CD8+ T cells from a representative experiment are shown in the bar graphs below. * p,.05 Shown is a
representative experiment from at least 3 experiments with 3–4 mice per group.
doi:10.1371/journal.pone.0108385.g004
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Results
Migration into infected tissue is required for CD8+ CD94/
NKG2A expression during virus infection
We have previously shown that the expression of NKG2A on
CD8+ T cells activated in response to influenza infection was not
observed in the MLN at any point throughout the course of
infection and clearance, but that expression was observed on
antigen-specific T cells harvested from the lung parenchyma at
various time points [28]. The timing of expression of NKG2A on
lung CD8+ T cells appears as virus titers were declining, suggesting
the possibility that antigen load influences NKG2A expression
(Figure 1). Since this raises the possibility of a relationship between
antigen recognition in the lung and NKG2A expression, we tested
this hypothesis with a transfer of MLN CD8+ T cells from A/
PR8/34-infected mice into other mice sub-lethally infected with
influenza B/Lee(Fig. 2a), which has no known cross-reactive T cell
epitopes. As shown in figure 2b, CD8+ T cells harvested at day 4
after A/PR8/34 infection from the MLN showed no expression of
NKG2A (histogram red area), as expected. When transferred into
a B/Lee-infected mouse, the donor MLN cells harvested from the
recipient MLN also show no such expression (Blue line), whereas
donor cells harvested from the lung expressed NKG2A (Green
line), indicating that specific antigen recognition in the lung was
not a requirement for NKG2A expression. We conclude that
either entry into an inflammatory milieu is sufficient to induce
expression, or that exit from the suppressive milieu of the MLN is
sufficient.
NKG2A ligation in vivo limits tissue injury during viral
clearance
Whether T cell exit from the MLN, or entry into the infected
tissue, is necessary for sufficient expression, the inhibitory activity
of NKG2A on CD8+ T cell effector function likely occurs in the
lung parenchyma. The combined observation of induced expres-
sion of NKG2A on antigen specific CD8+ T cells in influenza
infection, dampened cytokine production upon ligation of
NKG2A on CD8+ T cells, and the dramatic immunopathology
evident in Qa1-deficient mice upon CD8+ T cell clearance of
influenza infection strongly pointed to a key role of CD8+ T cell
NKG2A expression in abrogating tissue destruction during virus
clearance [28]. In order to formally confirm this hypothesis, we
generated NKG2A-null mice fully backcrossed into the B6
background (Figure 3). These mice demonstrated no defects in
the numbers of immune cells in naı¨ve mice examined at 6–8 weeks
of age, indicating (as expected) that these animals exhibit normal
immunological development prior to challenge (not shown).
Following intranasal influenza infection, NKG2A2/2 mice display
decreased frequency of CD8+ T cells (Fig. 4 Bottom middle) but
show similar frequencies of CD4+ (Fig. 4 Bottom Left) and NP366 -
specific CD8+ T cells (Figure 4 Bottom Right) the BAL when
compared to C57BL/6 (WT) mice. WT CD8+ T cells exhibit
induced expression of NKG2A on their surface while none was
observed on NKG2A2/2 CD8+ T cells (Fig. 4 FACS, right-hand
panels).
As noted above, influenza infection of Qa1b2/2 mice followed
by transfer of activated WT CD8+ effector cells resulted in
significant lung injury compared to WT controls [28]. And while
the role of Qa1b restricted CD8+ regulatory T cells has received
considerable recent attention [41,42], the respective role of Qa1b
interaction with NKG2A expressed on effector CD8+ T cells has
only been indirectly inferred by administration of blocking mAb to
NKG2A in a non-infectious model of T cell-mediated lung injury,
which resulted in enhanced immunopathology [28]. In order to
confirm that the immunopathology observed in the infected Qa1b-
deficient mice was in fact due to absent ligation of NKG2A, we
performed intranasal infection of NKG2A2/2 and WT mice with
0.5 LD50 of influenza virus A/PR/8/34 (PR8). Animals were
sacrificed 10 days post infection, and histologic analysis demon-
strated that NKG2A2/2 (Fig. 5B) mice had significantly more
inflammation in the lungs than wild-type B6 mice (Fig. 5A) and
summarized in Figure 5C. Histopathological analysis demonstrat-
ed enhanced thickening of the sub-mucosa, increased consolida-
tion, and diffuse alveolar damage. Inflammatory areas were
scattered throughout all lobes of the lung in both WT and mutant
mice.
Figure 5. NKG2A2/2 mice demonstrate greater lung damage
from enhanced inflammation during acute influenza infection.
Mice were intranasally infected with a sub-lethal dose of influenza A/
PR8/34. On day 10 post-infection, mice were euthanized by anesthesia
overdose and exsanguination. Lungs were process as in materials and
methods for histological sections, slides were H & E stained and
evaluated for histopathological damage. Percent of total area of
damaged lung per 46 field was calculated for each lung slice. Data is
presented as % inflamed lung. Data is representative of two distinct
experiments of 2–4 mice per group. **** p,0.0001.
doi:10.1371/journal.pone.0108385.g005
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Influenza infection results in increased inflammation and
inflammatory chemokine expression in NKG2A2/2 mice
To further characterize the inflammatory foci observed
histologically, we compared the number of cells in the lung
airways, cellular distribution, and cytokine/chemokine production
between C57BL/6 and NKG2A2/2 mice following influenza
infection. At 7–8 days post infection, NKG2A2/2 mice had
significantly greater numbers of cells in the lung airways than WT
mice after collection by BAL (Fig. 6A). The increase in cell
number appears to be the result of non-lymphoid cells as there was
no significant increase in macrophages, CD4+ T cells, or CD8+ T
cells. This increase in non-lymphoid cells was determined to be
PMN as determined by analysis of BAL cytospins (Fig. 6B)
Additionally, we observed significantly higher levels of TNF-a in
BALF of NKG2A2/2 than WT (Fig. 6D), as well as increased
MIG (Fig. 6E) and KC (Fig. 6F), indicating an enhanced cellular
and soluble inflammatory milieu in the mutant mice than in the
WT (as well as BAL fluid albumin and RBC [not shown],
indicators of alveolar injury).
Influenza specific NKG2A2/2 CD8+ T cells make increased
levels of effector cytokines following peptide
re-stimulation in vitro
We have previously observed that blockade of NKG2A during
in vitro stimulation of CD8+ T cells resulted in enhanced
production of TNF-a [28]. In addition, we observed increased
levels of TNF-a in the BALF at days 7–8-post influenza infection
of NKG2A2/2 mice compared to WT. We therefore examined
the ex vivo capacity of NKG2A2/2 influenza-specific CD8+ T
cells to produce TNF-a in-vitro by peptide stimulation. Bulk
cultures of NP366-specific CD8
+ T cells were generated from the
spleens of mice that had recovered from influenza infection, and
cultured with or without NP366 peptide. As shown by represen-
tative FACS plots in figure 7A, NKG2A2/2 NP366-specific CD8
+
T cells produced higher total levels of IFN-c and TNF-a than did
NP366-specific cells from WT mice after in vitro peptide
stimulation. The enhanced release of TNF-a (Fig. 7B) and IFN-
c (Fig. 7C) after in vitro stimulation by NKG2A2/2 mice was
further quantified by ELISA. NKG2A2/2 CD8+ T cells also
produced higher levels of IL-2 than did WT upon stimulation (not
shown). This indicates that antigen-specific CD8+ T cells from
NKG2A2/2 mice express greater effector activities upon stimu-
lation than WT, confirming our observations using antibody
blockade [28].
Infected WT recipients of transferred NKG2A2/2 CD8+ T
cells exhibit increased inflammation and enhanced
alveolar hemorrhage following lethal influenza challenge
The results shown above strongly suggest that the enhanced
immunopathology observed in influenza-infected NKG2A2/2
mice was a result of the absence of the inhibitory signal to antigen-
specific CD8+ T cells. However, NKG2A is expressed on NK cells
as well, and though NK cells appear to play no significant role in
influenza virus clearance or immunoregulation in influenza, we
endeavored to formally exclude the potential contribution of
NKG2A-deficiency on the NK cells to the observed immuno-
pathologic phenotype. We therefore performed adoptive transfer
of activated NKG2A2/2 CD8+ T cells (versus WT) into influenza-
infected WT mice. Bulk cultures of NP366-specific CD8
+ T cells
generated from NKG2A2/2 or WT mice were stimulated in vitro
Figure 6. NKG2A2/2 mice have increased cellularity and inflammatory cytokines at 10 days p.i. Influenza PR8 infection than WT
mice. Mice were intranasally infected with a sub-lethal dose of influenza A/PR8/34. On day 10 post-infection, cells were recovered from the BAL and
the (A) total number of cells was enumerated. Cytospin preparations from BAL were examined for PMN (B). BALF concentrations for (C) TNF-a, (D)
MIG, and (E) KC on day 10 post-infection were determined by Multiplex assay. Data are representative of two independent experiments of 5 mice per
group. *p,0.05, **p,0.01, and ***p,0.005.
doi:10.1371/journal.pone.0108385.g006
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and intravenously transferred to WT mice infected with a lethal
dose of influenza on the day prior to transfer. Mice were sacrificed
4 days after transfer (5 days post infection). WT mice receiving
NKG2A2/2 cells exhibited greater weight loss than recipients of
WT T cells following influenza infection (not shown). Histopath-
ological analysis confirmed that mice receiving NKG2A2/2 CD8+
T cells had more inflammatory foci (Fig. 8B and 8C) than did WT
mice receiving WT CD8+ T cells (Fig. 8A and 8C). Importantly,
beyond increased inflammation, alveolar hemorrhage was dra-
matically enhanced in infected recipients of NKG2A2/2 CD8+
T cells compared to WT (figure 8D), indicating that absence of
NKG2A only on effector CD8+ T cells is sufficient to drive
enhanced lung injury.
Adenovirus-infected NKG2A2/2 mice have enhanced
liver damage compared to wild-type mice
To examine whether regulation of effector CD8+ T cell function
by NKG2A extended beyond influenza infection, we examined the
consequence of NKG2A-deficiency during an acute infection with
murine adenovirus (Ad-OVA). Histological sections from livers of
WT and NKG2A2/2 mice infected seven days previously with
Ad-OVA were examined and we observed increased lymphocytic
infiltrate in the livers of NKG2A2/2 mice (Figures 9C, 9D)
compared to WT (Figures 9A, 9B). As a measure of liver injury,
serum alanine aminotransferase (ALT) was measured and we
observed an increase in serum ALT levels in NKG2A2/2 mice
compared to WT mice, 7 days after Ad-OVA infection
(Figure 9E). We also examined cytokine levels at day 7 post Ad-
OVA infection, and NKG2A2/2 mice had significantly higher
message levels for IFN-c than WT mice. This corresponds to the
increase in the absolute numbers of liver CD8+ T cells at this time
point (data not shown). In contrast to our observations in influenza
infection, the TNF-a mRNA levels after Ad-OVA infection were
not significantly different. There was also no difference in Ad-
OVA virus clearance between mutant and WT mice, confirmed
by qPCR of OVA mRNA (not shown). Thus, similar to influenza
virus infection, the lack of NKG2A resulted in enhanced liver
injury in adenovirus hepatitis.
Discussion
Virus infection frequently results in tissue injury as a
consequence of both the cytopathic effects of the virus as well as
the damage induced by immune-mediated virus clearance,
whether successful or not [15,20,43–45]. It has become increas-
ingly evident that the contribution of immune responses, both
innate and adaptive, to tissue injury may be much more significant
than previously appreciated. Greater understanding of the
pathogenesis of multiple virus infections has led to discovery of
multiple control mechanisms that have evolved to limit the
Figure 7. NP366-specific CD8
+ T cells derived from NKG2A2/2 mice have enhanced effector functions. (A) NP366-specific WT and
NKG2A2/2 CD8+ T cells were stimulated with NP366 peptide in the presence of brefeldin A and total production of TNF-a and IFN-c was analyzed by
FACS. Alternatively, ELISA was used to measure (B) TNF-a and (C) IFN-c production. Data are representative of at least two experiments with 3–5 mice.
*p,0.05 and ***p,0.005.
doi:10.1371/journal.pone.0108385.g007
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immunopathologic impact on tissue structural and functional
integrity. This appears to be advantageous to the host even when
virus clearance is unsuccessful, such as in polyoma virus infection,
LCMV, HIV, and hepatitis [25,46–48]. The mechanisms of both
tissue injury and maintenance of integrity largely overlap with
antiviral effector functions, such as type I interferon, which is both
antiviral and anti-inflammatory [49]. Effector activities of both
innate and adaptive immune cells, including production of IFN-c
and TNF-a, which are both antiviral and pro-inflammatory, but
also the anti-inflammatory cytokine, IL-10 [21], are subject to
counter regulation. This counter regulation presumably serves to
limit injury and allow maintenance of tissue integrity and function,
a balance, which is critical to the survival of the infected host.
Counter regulatory, i.e. inhibitory receptors, for innate cells such
as NK cells are well described. Several inhibitor molecules on
CD8+ T cells have been also reported which are expressed at
various time points after infection, such as CTLA-4, PD-1, TIM-3,
among others [22].
In this study, we demonstrated that NKG2A, an inhibitory
receptor normally associated with NK cells, negatively controls the
function of effector CD8+ T cells and the extent of injury during
two different viral infections, influenza virus and adenovirus.
Expression of NKG2A on CD8+ T cells occurred exclusively in the
lung late during influenza infection (i.e. day 8), when virus titers
were falling, suggesting an important role for NKG2A in
resolution of the effector phase. In support of this hypothesis,
NKG2A ligation with cognate receptor functioned to limit CD8+
T cell effector functions, as CD8+ T cell production of effector
cytokines, TNF-a and IFN-c, was enhanced in the absence of
NKG2A. Enhanced cytokine production resulted in exacerbated
lung and liver injury during influenza virus and adenovirus
infection, respectively. Importantly, complete absence of NKG2A
or absence of NKG2A only on effector CD8+ T cells did not
impair viral clearance. Taken together, these observations identify
NKG2A as a critical negative regulator of CD8+ T cells, limiting
effector function and the extent of injury during viral infection,
while permitting successful clearance of infection.
Our data suggests that the exacerbated tissue injury observed
during both adenovirus and influenza virus infection was largely
due to enhanced CD8+ T cell effector functions. During
adenovirus infection, enhanced hepatocellular injury observed in
the absence of NKG2A correlated with an increase in the absolute
numbers of CD8+ T cells and IFN-c expression in the liver. This is
consistent with other models of liver infection where the onset of
hepatocellular injury correlates with the acquisition effector
functions of CD8+ T cells [50]. In the context of influenza
infection, despite no changes in the absolute numbers of CD8+ T
cells in the airways in the absence of NKG2A, we observed
increased levels of effector CD8+ T cell cytokines, such as TNF-a.
This was presumably due to increased production of TNF-a by
influenza-specific CD8+ T cells as NKG2A-deficiency resulted in
enhanced production of TNF-a and IFN-c by these cells in vitro.
We have previously shown that TNF-a production by influenza-
specific CD8+ T cells is critical for the development of severe and
Figure 8. Transferred NKG2A2/2 CD8+ T cells are more inflammatory following intranasal influenza PR8 infection than transferred
WT CD8+ T cells. Whole lung histology on day 5 post-infection from mice receiving either (A) WT or (B) NKG2A2/2 NP366-specific CD8
+ T cells after
lethal challenge with influenza A/PR8/34 virus. Shown are representative slides from at least 2 separate experiments at 106 and 406(inset) with
overall histolopathological score was determined as described in Materials and Methods(C). Hemorrhage after T cell transfer was enumerated by
counting the number of RBCs from multiple 406 fields of tissues from multiple mice (D). Data are representative of the results of two experiments
with 3–5 recipient mice per group. *p,0.0001.
doi:10.1371/journal.pone.0108385.g008
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lethal lung injury during influenza infection [28]. The mechanisms
by which expression of TNF-a by influenza-specific CD8+ T cells
mediate this lethal injury are through the induction of chemokines
by alveolar epithelial cells and the subsequent recruitment of
inflammatory cells into the lungs [28]. Consistent with our
previous observations, we observed enhanced levels of chemo-
kines, such as MIG and KC, in the absence of NKG2A and
subsequently, increased numbers of inflammatory cells in the
airways and exacerbated lung injury. Absence of NKG2A only on
influenza-specific CD8+ T cells also resulted in exacerbated lung
injury, indicating that NKG2A primarily functioned by regulating
the extent of effector CD8+ T cell-mediated immunopathology.
Interestingly, increased levels of TNF-a, MIG, and KC have been
observed in models of highly pathogenic influenza infection
[26,51,52], suggesting that failure to properly regulate expression
of NKG2A on effector cells may contribute in part to enhanced
expression of pro-inflammatory mediators and exacerbated
pulmonary pathology during highly pathogenic influenza
infection.
These observations raise the critical question of what are the
mechanisms that regulate NKG2A expression on effector CD8+ T
cells during virus infection. We have previously shown that
NKG2A expression is absent on naive CD8+ T cells, but was
induced in response to influenza infection [28]. Interestingly, we
show here that the expression of NKG2A occurs only in the
periphery and only when virus titers (and antigen load) were
waning. This is somewhat curious, since we found that specific
antigen in the periphery was unnecessary for expression. The
nature of the signal(s) which lead to CD8+ NKG2A expression
have not been clearly identified. While various in vitro studies
have suggested that IL-15 or IL-10 may play a role in induction of
CD8+ NKG2A expression [26,52,53], we were unable to
demonstrate any such effect of these cytokines in vivo (not shown).
One tantalizing in vitro study suggested that high levels of IL-2
(and presence of CD28) inhibited expression of NKG2A on CD8+
T cells [54], which raises the interesting possibility that higher IL-2
levels in the MLN than in the periphery may account for the
anatomical predilection for NKG2A expression in the lung. Thus,
as with some of the other aforementioned molecules that dampen
Figure 9. NKG2A2/2 mice have greater liver inflammation and enhanced cellular damage following Adenovirus infection than WT
mice. H & E stained histological sections of liver from WT mice at (A) 106 and (B) 406or NKG2A2/2 mice at (C) 106 and (D) 4067 days post Adv
infection. Serum alanine transaminase (ALT) levels 7 days post Adv infection. Data are representative of two independent experiments of three mice
per group. *p,0.01.
doi:10.1371/journal.pone.0108385.g009
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or suppress effector T cell responses with a variety of other
mechanisms, NKG2A on CD8+ T cells appears to modulate
effector cytokine and chemokine production allowing a transition
to recovery. While there are many redundancies of inhibition
pathways, we have shown that deletion of NKG2A on CD8+ T
cells can have a direct and non-redundant detrimental effect
resulting in increased immunopathology following virus infections.
In summary, we have shown that antiviral CD8+ T cells have an
additional control mechanism in NKG2A expression, which we
hypothesize allows for fine control of effector function in the
context of virus clearance. We propose that this, and other such
mechanisms, are critically important regulators which fine-tune
CD8+ T cell effector functions, serving to clear virus from
physiologically critical tissues while minimizing tissue injury and
allowing maintenance of structural and functional integrity so
important to survival of the host.
Supporting Information
Figure S1 Probe sequence (562 bp) for detecting NKG2A
knockout, heterozygous, and WT mice by Southern blot,
consisting of NcoI-digested tail-tip DNA. Underlined
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used to amplify the probe with digoxygenin-labeled UTP from a
plasmid containing a portion the NKG2A gene in the Balb/c
mouse. This probe sequence corresponds to the range of
131393104 to 131393665 of Mm_Celera alternate assembly on
mouse chromosome 6, accession number AC_000028.1.
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